These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35474237)

  • 1. Automatic assessment of adverse drug reaction reports with interactive visual exploration.
    Gao Z; Yang Y; Meng R; Yu J; Zhou L
    Sci Rep; 2022 Apr; 12(1):6777. PubMed ID: 35474237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian generating function approach to adverse drug reaction screening.
    Northardt T
    PLoS One; 2024; 19(1):e0297189. PubMed ID: 38241386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study.
    Sharma M; Baghel R; Thakur S; Adwal S
    BMJ Open; 2021 Oct; 11(10):e052737. PubMed ID: 34607871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
    Pandit S; Soni D; Krishnamurthy B; Belhekar MN
    J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
    Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.
    Impicciatore P; Mucci M
    Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
    Belhekar MN; Taur SR; Munshi RP
    Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of adverse drug reaction/adverse event and early warning signal mining of Ginkgo biloba Dropping Pills based on SRS data].
    Zhang C; Liu H; Xie YM; Wang Q
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2322-2328. PubMed ID: 32495588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes.
    Rawat BPS; Jagannatha A; Liu F; Yu H
    AMIA Annu Symp Proc; 2020; 2020():1041-1049. PubMed ID: 33936480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
    Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
    J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding.
    McMaster C; Liew D; Keith C; Aminian P; Frauman A
    Drug Saf; 2019 Jun; 42(6):721-725. PubMed ID: 30725336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty.
    Brvar M; Fokter N; Bunc M; Mozina M
    BMC Clin Pharmacol; 2009 May; 9():8. PubMed ID: 19409112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.